Cromos Pharma recruits 473 patients (92% of total) into a breast cancer trial, all in under 7 months.
17 June 2019
Budapest, Hungary. We are happy to announce that Cromos Pharma has just completed the recruitment of a large registration breast cancer trial. The trial is being conducted in 9 countries and is being performed in collaboration with an international academic group. Initially contracted with recruiting 200 patients across 4 countries, Cromos has exceeded everyone's expectations by completing this task in less than 3 months. This prompted the sponsor to increase the number of patients first to 350 and then to 450. At the end Cromos team had recruited 473 patients, all in under 7 months.
Back to the news
When it comes to accelerated and rescue recruitment, Cromos Pharma customarily beats its competition by a factor of 3 or more.